Women’s health company Renovia has raised $25.3 million in a new round of equity financing, according to a recently posted SEC filing.
Renovia created and produces the Leva pelvic floor strengthening system designed to aid individuals suffering from pelvic floor disorders. The system contains sensor technology that allows the user to see the position of their pelvic floor muscles and movement created during exercises, according to the company’s website.
The Leva device is FDA cleared for rehabilitating and training weak pelvic floor muscles for treating stress incontinence, mild to moderate urge incontinence and mixed incontinence in women, according to the site.
Money in the round came from 13 unnamed investors, with the first sale noted as occurring on July 13, according to the filing.
The Boston-based company is looking for an additional $7.5 million before closing the round, according to the filing, and has not yet publicly stated how it plans to spend the funds raised in the offering.